KELSEY MOAKLER: Open Payments
NPI 1528423647 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,228 in 233 payments from 36 companies in 2025. Trend: 2023 $2,176 · 2024 $3,066 · 2025 $4,228
Food & beverage: $4,228
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 115 | $1,398 |
| Regeneron Healthcare Solutions, Inc. | 10 | $383 |
| Novartis Pharmaceuticals Corporation | 21 | $360 |
| AstraZeneca Pharmaceuticals LP | 10 | $200 |
| Karyopharm Therapeutics Inc. | 4 | $133 |
| Sumitomo Pharma America, Inc. | 6 | $128 |
| BeOne Medicines USA, Inc. | 4 | $121 |
| Exelixis Inc. | 4 | $120 |
| Geron Corporation | 4 | $100 |
| SOBI, INC | 3 | $93 |
Products named: Enhertu, DATROWAY, LIBTAYO, KISQALI, BRUKINSA, IMFINZI, XPOVIO, ORGOVYX.
Industry payments across NV — which companies pay providers there.
